Page 58
allied
academies
J Clin Exp Tox 2017 | Volume 1 | Issue 2
Toxicology and Pharmacology
November 01-02, 2017 | Toronto, Canada
International Conference on
B
enign prostate hyperplasia (BPH) is a urological disorder
caused by the noncancerous enlargement of the prostate
as men age. As the prostate enlarges, it can constrict the
urethra, inducing various symptoms including a weak urinary
stream, incomplete bladder emptying, nocturia, dysuria and
bladder outlet obstruction. Conventionally used drugs like
5 α -reductase inhibitors and α adrenoceptors antagonists
are used to treat benign prostatic hyperplasia, but they
possess various side effects like impotence, decreased
libido, ejaculation disorder, gynaecomastia, dizziness, upper
respiratory tract infection, headache, fatigue and chest pain,
also it was found in our previous study combination of fatty
acid like lauric and myristic acid can be used for treatments
of benign prostatic hyperplasia with minimum side effects
so present study undertaken to compare side effects of
conventionally used drugs and fatty acid, and hence so
present study investigated to compare toxicological potential
of combined therapy with doses of finasteride and alfuzosin
to lauric and myristic acid orally administered for 28 days to
male Sprague Dawley rats. Male animals were randomized
into three groups of six animals each one: a control group
treated only with the vehicle and two groups treated with
combination of, Finasteride (50 mg/kg)+Alfuzosin (50 mg/
kg) {FA}, and Lauric acid (180 mg/kg) + myristic acid (70 mg/
kg) {LA}, respectively. The variables analyzed were done like
mortality, clinical signs, body weight, food consumption,
hematology and blood parameters, relative organ weight
and histopathological findings. Treatment with FA and LA
combined therapy significantly reduced the relative organ
weight of sex organs in animals treated. In conclusion, the
combined therapy orally administered to male rats did
not induce toxicological effects except the atrophy of the
accessory sex organs related to FA administration, weight
gain in fatty acid treatment groups so results show both
combinations are relatively safe for the treatments of benign
prostatic hyperplasia.
e:
anuppatil.pharma@gmail.comComparative toxicological evaluation of the combined therapy of finasteride and alfuzosin to lauric acid
and myristic acid in male rats
Anup A Patil
Krishna Institute of Medical Sciences Deemed University, India